Dear Sir/Madam,Pursuant to Regulation 33 and Regulation 30 read with Part-A of Schedule III of SEBI (LODR) Regulations, 2015, we hereby inform you that the Board of Directors of the Company at its Meeting held today i.e. 14th November, 2025 has inter-alia adopted and approved 1) The Standalone Un-Audited Financial Results for the Quarter and Half year ended on 30th September, 2025.2) Limited Review Report by Statutory Auditors of the Company on Standalone Un-Audited Financial Results for the Quarter and Half year ended on 30th September, 2025.The meeting of the Board of Directors commenced at 03:30 P.M. and concluded at 04:25 P.M.This is for your information and record.
Board Meeting Outcome for Outcome Of The Board Meeting Held On 14Th November, 2025
On 6ix: 6ix.com/news/board-meeting-outcome-for-outcome-of-the-board-meeting-held-on-14th-november-2025-3
View original source (BSE India)Rekvina Laboratories Ltd. on 6ix
Earlier from Rekvina Laboratories
- Rekvina Laboratories Ltd. Press Release Nov 05 2025
- Board Meeting Intimation for Intimation Of Board Meeting To Be Held On 14Th November, 2025.
- Rekvina Laboratories Ltd. Press Release Oct 13 2025
- Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
- Rekvina Laboratories Ltd. Press Release Oct 06 2025
Later from Rekvina Laboratories
- Standalone Financial Result For The Period Ended On 30 September 2025
- Non-Applicability Of Regulation 23(9) Of SEBI (Listing Obligations And Disclosure Requirements) (Amendment) Regulations, 2018, For The Half Year Ended On 30.09.2025.
- Rekvina Laboratories Ltd. Press Release Nov 14 2025
- Closure of Trading Window
- Rekvina Laboratories Ltd. Press Release Dec 26 2025
Follow Rekvina Laboratories into a list and get an email when it puts out news.
Follow Rekvina Laboratories